Impact of Cancer on Memory Functioning: Understanding Disorders Using Approaches in Neuropsychology and Neuroimaging

Inclusion Criteria for patients: * Patients aged 45 and over * Patients from Grade 3 'end of primary schooling "minimum (scale Barbizet) * Non-Metastatic Breast Cancer * Adjuvant Chemotherapy: FEC, including Docetaxel Protocols * No major cognitive impairment * No previous neurological * Lack of personality disorders and psychiatric disorders evolutionary * Having signed the informed consent of study participation Inclusion Criteria for control group: * Women from the general population aged 45 and over, and matched in age and cultural level in patients * Topics of Grade 3 'end of primary schooling "minimum (scale Barbizet) * No prior cancer * No major cognitive impairment * No previous neurological * Lack of personality disorders and psychiatric disorders evolutionary * Participating in the IMAP Protocol No. ID-BCR: 2007-A00414-49 or IMAP+(n° ID RCB 2011-A01493-38)(see how the study below) have signed forms no objection and consent to study participation Exclusion Criteria: Traduction (français \> anglais) * Metastatic * Cancer of the breast other than primitive * Patients with paraneoplastic syndrome * Patients under 45 years * Patients whose achievement is below level 3 'end of primary schooling "(scale Barbizet) * Patients with adjuvant chemotherapy is associated with targeted therapy * Patients who have received other cancer treatments (chemotherapy or radiotherapy brain) * Contraindication to the implementation of an MRI (claustrophobia, metal objects in the body) * disorders of higher functions existing in the administration of chemotherapy * Neurologic earlier * Pathology psychiatric evolutionary * Refusal of participation * Patients unable to meet the cognitive tests * Drug use * Heavy drinking